Skip to main content
  • 41 Accesses

Abstract

Calcium antagonists (CA) are important drugs used mainly in the treatment of various types of hypertension [15, 20, 22]. Their effect on the kidney in health and disease has been excellently reviewed [15, 18, 19]; therefore, I thought it much more reasonable, instead of trying to concoct another review article, to report on experiments carried out in our laboratory adressing this topic. Vasodi– latation seems to be the main effect of CA, and this also encompasses the kidney [3, 24, 26], especially its main resistance vessels, the afferent and efferent arterioles. In a hydronephrotic kidney, vasodilatation is more pronounced on the afferent than on the efferent arteriole [4, 17]; this could be dangerous since an increase in glomerular capillary pressure followed by hyperfiltration may occur, both events supposed to be deleterious [1, 11]. However, the hydronephrotic kidney is a rather sophisticated preparation far from the physiological State. Therefore, we decided to study this question in anesthetized dogs in which the CA were infused directly into the left renal artery (LRA) at a dose not influencing systemic blood pressure [8]. Nevertheless, the acute effects of CA are clinically not very important, since hypertensive patients take the drugs regularly and over long periods of time. The effect of systemic long–term administration of CA was studied in rats.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brenner BM (1985) Nephron adaptation to renal injury or ablation. Am J Physiol 249: F324–F337

    PubMed  CAS  Google Scholar 

  2. Burke TJ, Singh H, Schlier RW (1990) Calcium handling by renal tubules during oxygen deprivation injury to the kidney prior to reoxygenation. Cardiovasc Drugs Ther 4: 1319–1324

    Article  PubMed  CAS  Google Scholar 

  3. Carmines PK, Mitchell KD, Navar LG (1992) Effects of calcium antagonists on renal hemodynamics and glomerular function. Kidney Int 41 [Suppl 36]: S–43–S–48

    Google Scholar 

  4. Fleming JT, Parekh N, Steinhausen M (1987) Calcium antagonists preferentially dilate preglomerular vessels of hydronephrotic kidney. Am J Physiol 253: Fl 157–Fl 163

    Google Scholar 

  5. Harris DCH, Hammond WS, Burke TJ, Schlier RW (1987) Verapamil protects against progression of experimental chronic renal failure. Kidney Inter 31: 41–46

    Article  CAS  Google Scholar 

  6. Heller J, Horäcek V (1980) Comparison of directly measured and calculated glomerular capillary pressure in the dog kidney. Pflugers Arch 385: 253–258

    Article  PubMed  CAS  Google Scholar 

  7. Heller J, Horäcek V (1984) Kidney function during decreased perfusion pressure due to aortic clamping and hemorrhagic hypotension: a Single nephron study in the dog kidney. Renal Physiol 7: 90–101

    PubMed  CAS  Google Scholar 

  8. Heller J, Horäcek V (1990) The effect of two different calcium antagonists on the glomerular haemodynamics in the dog. Pflugers Arch 415: 751–755

    Article  PubMed  CAS  Google Scholar 

  9. Heller J, Hellerova S, Dobesova Z, Kunes J, Zicha J (1993) The Prague hypertensive rat - A new model of genetic hypertension. Clin Exp Hypertens 15: 807–818

    Article  PubMed  CAS  Google Scholar 

  10. Heller J, Schubert G, Havlickovä J, Thurau K (1993) The role of the kidney in the development of hypertension: a transplantation study in the Prague hypertensive rat. Pflugers Arch 425: 208–212

    Article  PubMed  CAS  Google Scholar 

  11. Hostetter TH, Rennke HG, Brenner BM (1982) The case for intrarenal hypertension in the intiation and progression of diabetic and other glomerulopathies. Am J Med 72: 375–380

    Article  PubMed  CAS  Google Scholar 

  12. Ichikawa I, Miele JF, Brenner BM (1979) Reversal of renal cortical actions of angiotensin II by Verapamil and manganese. Kidney Int 16: 137–147

    Article  PubMed  CAS  Google Scholar 

  13. Ito S, Ueda Y, Sugisaki T, Iidaka K (1992) Induction of glomerular injury by singlet oxygen. Nephron 60: 204–209

    Article  PubMed  CAS  Google Scholar 

  14. Kazda S, Hirth C, Stasch J-P (1988) Diuretic effect of nitrendipine contributes to its antihypertensive efficacy: a review. J Cardiovasc Pharmacol 12 [Suppl 4]: S1–S5

    Article  PubMed  CAS  Google Scholar 

  15. Kazda S, Knorr A (1990) Calcium antagonists. In: Ganten D (ed) Pharmacology of antihypertensive therapeutics. Springer, Berlin Heidelberg New York, pp 301–375 (Handbook of experimental pharmacology, vol 93 )

    Google Scholar 

  16. Knorr A, Kazda S, Neuser D, Stasch J-P, Seuter F (1991) Long-term protective effects of nitrendipine in experimental hypertension. J Cardiovasc Pharmacol 18 [Suppl 15]: 1–4

    Google Scholar 

  17. Loutzenheiser R, Epstein M (1985) Effects of calcium antagonists on renal hemodynamics. Am J Physiol 249: R889–R893

    Google Scholar 

  18. Neumayer H–H, Kunzendorf U (1991) Renal protection with the calcium antagonists. J Cardiovasc Pharmacol 18 [Suppl 1]: S1l–S18

    Google Scholar 

  19. Reams GP, Bauer JH (1990) Effects of calcium antagonists on the hypertensive kidney. Cardiovasc Drugs Ther 4: 1331–1336

    Article  PubMed  CAS  Google Scholar 

  20. Scriabine A, Kazda S (1989) Pharmacological basis for use of calcium antagonists in hypertension. Magnesium 8: 253–265

    PubMed  CAS  Google Scholar 

  21. Shimizu T, Kawataba T, Nakamura M (1990) Protective effect of a novel calcium blocker, S–312–d, on ischemic acute renal failure in rat. J Pharmacol Exp Ther 255: 484–490

    PubMed  CAS  Google Scholar 

  22. Spivack C, Ocken S, Frishman WH (1983) Calcium antagonists. Clinical use in the treatment of systemic hypertension. Drugs 25: 154–163

    Google Scholar 

  23. Stasch JP, Kazda S, Hirth-Dietrich C, Neuser D (1990) Effects of nisoldipine on atrial natriuretic peptides, blood pressure and cardiac hypertrophy in Dahl rats. Clin Exp Hypertens 12: 1419–1436

    Article  CAS  Google Scholar 

  24. Sterzl RB (1987) Renal actions of calcium antagonists. J Cardiovasc Pharmacol 10 [Suppl 10]: S17–S21

    Google Scholar 

  25. Stratta P, Canaves C, Dogliani M, Mazzucco G, Monga G, Vercellone A (1991) The role of free radicals in the progression of renal disease. Am J Kidney Dis 17: 33–37

    PubMed  CAS  Google Scholar 

  26. Tarazi RC, Conway J (1983) Regional hemodynamicc. In: Genest J, Kuchel O, Hamet P, Cantin M (eds) Hypertension, 2nd edn. McGraw-Hill, New York, pp 31–42

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Heller, J. (1995). Influence of Calcium Antagonists on Kidney Function of Hypertensive Rats. In: Garthoff, B., Knorr, A.M., Busse, WD., Seuter, F. (eds) Experimental Hypertension and Therapeutic Progress: Vasodilation and Beyond. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79338-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-79338-7_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-58545-9

  • Online ISBN: 978-3-642-79338-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics